We at Delex are committed to the Regulatory, Quality, and Safety compliance of our products. We strive for excellence in ensuring product compliance with FDA regulations, quality, and ethical standards.

Guided with the company’s core values, we practice openness of the regulatory process: features of regulatory transparency include clarity of regulatory roles, responsibilities, and objectives, predictability of decisions, accountability, stakeholder participation, and open access to reliable information published in the public domain. Such transparency increases the legitimacy of our Regulatory Department and its partnership with our customers and stakeholders.

While we are dedicated to the principle of transparency, we will continue to deliver cost-effective critical care products by upholding our mission and vision. We aim to assure that Filipino patients will have the right of access to high-quality, safe, and effective pharmaceutical products and medical devices.


We manifest and value integrity in all aspects of our business operations in the finance department by being transparent. We ensure that our records adhere to the generally accepted accounting principles and international financial reporting standards, as we forged a partnership with one of the biggest auditing firms in the country.  Thus, we have comprehensive maintenance of accounts as well as in the prevention and detection of errors and frauds.
Moreover, we utilize Systems Applications and Products in Data Processing (SAP) as our enterprise resource planning. It safely records our financial and logistic transactions. Delex Pharma has always been transparent and will continue to safeguard its financial management to the interest of its partners and stakeholders.